\begin{longtable}{lcccccc}
\caption{Inference for M 18antibody marker covariate-adjusted correlates of risk of HPV pooled over treatment arms: Odds ratios per 10-fold increment in the marker*} \\ 
   \hline
 
         \multicolumn{1}{l}{IARC_HPV} & \multicolumn{1}{c}{No. cases /}   & \multicolumn{2}{c}{OR per 10-fold incr.}                     & \multicolumn{1}{c}{P-value}   & \multicolumn{1}{c}{q-value}   & \multicolumn{1}{c}{FWER} \\ 
         \multicolumn{1}{l}{Immunologic Marker}            & \multicolumn{1}{c}{No. at-risk**} & \multicolumn{1}{c}{Pt. Est.} & \multicolumn{1}{c}{95\% CI} & \multicolumn{1}{c}{(2-sided)} & \multicolumn{1}{c}{***} & \multicolumn{1}{c}{} \\ 
         \hline
 
    Anti L1, L2 IgG HPV6 (AU/ml) & 26/3,023 & 0.76 & (0.44-1.33) & 0.340 & 0.810 & 1.000 \\ 
  Anti L1, L2 IgG HPV11 (AU/ml) & 26/3,023 & 0.91 & (0.53-1.56) & 0.724 & 0.810 & 1.000 \\ 
  Anti L1, L2 IgG HPV16 (IU/ml) & 26/3,023 & 0.87 & (0.51-1.50) & 0.626 & 0.810 & 1.000 \\ 
  Anti L1, L2 IgG HPV18 (IU/ml) & 26/3,023 & 0.62 & (0.39-1.01) & 0.052 & 0.405 & 0.525 \\ 
  Anti L1, L2 IgG HPV31 (AU/ml) & 26/3,023 & 1.44 & (0.54-3.86) & 0.465 & 0.810 & 1.000 \\ 
  Anti L1, L2 IgG HPV33 (AU/ml) & 26/3,023 & 4.01 & (0.01-1770.99) & 0.655 &     &     \\ 
  Anti L1, L2 IgG HPV45 (AU/ml) & 26/3,023 & 0.31 & (0.04-2.63) & 0.281 &     &     \\ 
  Anti L1, L2 IgG HPV52 (AU/ml) & 26/3,023 & 1.38 & (0.27-7.06) & 0.702 &     &     \\ 
  Anti L1, L2 IgG HPV58 (AU/ml) & 26/3,023 & 1.29 & (0.24-7.11) & 0.766 &     &     \\ 
  Anti L1, L2 IgG Score & 26/3,023 & 0.90 & (0.55-1.47) & 0.687 &     &     \\ 
   \hline
\hline
\label{tab:CoR_univariable_logistic_pretty}
\end{longtable}
